Baylis Medical Technologies today announced the 510(k) clearance and launch of the PowerWire Pro radiofrequency (RF) guidewire in the USA, facilitating venous stent recanalisation for total occlusions.
Patients with stenotic or occluded peripheral vessels often undergo stent placement to restore vessel patency and normal blood flow. Unfortunately, stents can re-occlude, requiring additional interventions. A press release notes that the PowerWire Pro RF guidewire has been designed to address this challenge by employing radiofrequency technology to cross totally occluded stents in peripheral vessels. Its design allows selective application of RF energy to cross segments of the occlusion that cannot be traversed mechanically, the company notes. When contacting metal, the RF energy terminates, reducing the potential for vessel extravasation when crossing in-stent occlusions.
The addition of the PowerWire Pro RF guidewire to Baylis Medical Technologies’ portfolio of radiofrequency wires expands its clinical solutions in radiology and vascular surgery.
Frank Baylis, executive chairman of Baylis Medical Technologies, expressed enthusiasm about the PowerWire Pro RF guidewire’s potential impact, stating: “We are very excited to announce new additions to our family of PowerWire RF guidewires. With these new tools, healthcare professionals will now be able to treat patients suffering from both native and in-stent peripheral occlusions using our radiofrequency puncture technology. The PowerWire Pro RF guidewire broadens the doctors’ capabilities in treating such occlusions, where traditional methods have previously fallen short.”
